BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 21033070)

  • 41. Collagenase for recurrent dupuytren contracture with skin grafts.
    Denkler K
    J Hand Surg Am; 2013 Jun; 38(6):1264. PubMed ID: 23707028
    [No Abstract]   [Full Text] [Related]  

  • 42. The Efficacy and Safety of Concurrent Collagenase Clostridium Histolyticum Injections for 2 Dupuytren Contractures in the Same Hand: A Prospective, Multicenter Study.
    Gaston RG; Larsen SE; Pess GM; Coleman S; Dean B; Cohen BM; Kaufman GJ; Tursi JP; Hurst LC
    J Hand Surg Am; 2015 Oct; 40(10):1963-71. PubMed ID: 26216077
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enzyme injection as nonsurgical treatment of Dupuytren's disease.
    Badalamente MA; Hurst LC
    J Hand Surg Am; 2000 Jul; 25(4):629-36. PubMed ID: 10913202
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data.
    Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Lindau T
    J Hand Surg Am; 2015 Aug; 40(8):1597-605. PubMed ID: 26096221
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Budget impact analysis in Spanish patients with Dupuytren's contracture: fasciectomy vs. collagenase Clostridium histolyticum.
    De Salas-Cansado M; Cuadros M; Del Cerro M; Arandes JM
    Chir Main; 2013 Apr; 32(2):68-73. PubMed ID: 23507313
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Toxic dermatitis secondary to treatment with collagenase clostridium histolyticum for Dupuytren´s disease.
    Sanjuan-Cervero R; Poquet-Jornet JE; Carrera-Hueso FJ
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3688-91. PubMed ID: 27649672
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Response to the comment of Mr. J. Henderson on paper "Anaesthesia in the colagenase clostridium histolyticum injection for Dupuytren's disease: A cohort analysis"
    Sanjuan-Cervero R
    J Plast Reconstr Aesthet Surg; 2019 Mar; 72(3):513-527. PubMed ID: 30591365
    [No Abstract]   [Full Text] [Related]  

  • 48. Cost Comparison of Collagenase Clostridium Histolyticum and Fasciectomy for Treatment of Dupuytren's Contracture in the Australian Health System.
    Sefton AK; Smith BJ; Stewart DA
    J Hand Surg Asian Pac Vol; 2018 Sep; 23(3):336-341. PubMed ID: 30282551
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of collagenase in patients who did and did not have previous hand surgery for Dupuytren's contracture.
    Bainbridge C; Gerber RA; Szczypa PP; Smith T; Kushner H; Cohen B; Hellio Le Graverand-Gastineau MP
    J Plast Surg Hand Surg; 2012 Sep; 46(3-4):177-83. PubMed ID: 22670890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New insights into the immediate outcome of collagenase injections for Dupuytren's contracture.
    Warwick DJ; Graham D; Worsley P
    J Hand Surg Eur Vol; 2016 Jul; 41(6):583-8. PubMed ID: 26307140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adverse effects associated with collagenase clostridium histolyticum in Dupuytren disease: A prospective study.
    Sanjuan-Cerveró R; Carrera-Hueso FJ; Vazquez-Ferreiro P
    Orthop Traumatol Surg Res; 2018 Oct; 104(6):901-905. PubMed ID: 30253866
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Skin Laceration in Collagenase Clostridium histolyticum Treatment for Dupuytren's Contracture.
    Sanjuan-Cervero R; Carrera-Hueso FJ; Oliver-Mengual S; Ramon-Barrios MA; Peimer CA; Fikri-Benbrahim N
    Orthop Nurs; 2018; 37(2):144-153. PubMed ID: 29570549
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Collagenase clostridium histolyticum for dupuytren contracture: patterns of use and effectiveness in clinical practice.
    Peimer CA; Skodny P; Mackowiak JI
    J Hand Surg Am; 2013 Dec; 38(12):2370-6. PubMed ID: 24140362
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In Reply.
    Peimer CA;
    J Hand Surg Am; 2015 Nov; 40(11):2317-8. PubMed ID: 26518324
    [No Abstract]   [Full Text] [Related]  

  • 55. Current role of the collagenase Clostridium histolyticum in Dupuytren's disease treatment.
    Sanjuan-Cervero R
    Ir J Med Sci; 2020 May; 189(2):529-534. PubMed ID: 31713028
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cold intolerance following collagenase Clostridium histolyticum treatment for Dupuytren contracture.
    King IC; Belcher HJ
    J Hand Surg Am; 2014 Apr; 39(4):808-9. PubMed ID: 24679915
    [No Abstract]   [Full Text] [Related]  

  • 57. In reply.
    Swanson JW; Watt AJ; Vedder NB
    J Hand Surg Am; 2013 Jun; 38(6):1264-5. PubMed ID: 23707029
    [No Abstract]   [Full Text] [Related]  

  • 58. Nonsurgical approach unlocks contracted fingers.
    Harv Womens Health Watch; 2009 Nov; 17(3):6-7. PubMed ID: 20069741
    [No Abstract]   [Full Text] [Related]  

  • 59. A
    Pess GM; Sundbom M; Wilson K; Lindqvist D; Dahlin LB
    J Plast Surg Hand Surg; 2018 Oct; 52(5):301-306. PubMed ID: 30039732
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of resources and costs associated with the treatment of Dupuytren's contracture at an orthopedics and traumatology surgery department in Denia (Spain): collagenase clostridium hystolyticum versus subtotal fasciectomy.
    Sanjuan Cerveró R; Franco Ferrando N; Poquet Jornet J
    BMC Musculoskelet Disord; 2013 Oct; 14():293. PubMed ID: 24125161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.